Uncategorized
Omeros posts $14 million loss in third quarter
Omeros reported a net loss of $14 million, or $0.34 per share, in the third quarter compared with a net loss of $19.9 million, or $0.53 per share, in the same quarter of 2015, according to a press release.Total revenues for the quarter were $11.3 million and were all related to sales of Omidria (phenylephrine 1% and ketorolac 0.3% injection). In the third quarter of 2015, those revenues were $3.2 million.